{
    "SPADE_UN_13955": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13955",
            "Peptide Name": "Vpr-1",
            "Source": "Synthetic construct(derived from HIV-1 gene products(Vpr))",
            "Family": "Retroviridae",
            "Gene": "Not found",
            "Sequence": "LQQLLF",
            "Sequence Length": 6,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.20586421]HIV-1:Inhibition of 3′-end processing catalyzed by integrase(IC50>11 µM);inhibition of strand transfer catalyzed by integrase(IC50=68±1.0 µM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "Integrase",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Acetylation",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C37H60N8O9",
            "Mass": 760.92,
            "PI": 5.53,
            "Net Charge": 0,
            "Hydrophobicity": 1.2,
            "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min",
            "Mechanism of action": "IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3′-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication.",
            "Literature": [
                {
                    "Title": "Peptide HIV-1 integrase inhibitors from HIV-1 gene products.",
                    "Pubmed ID": "20586421",
                    "Reference": "J Med Chem. 2010 Jul 22;53(14)5356-60.",
                    "Author": "Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=20586421"
                }
            ],
            "Frequent Amino Acids": "LQF",
            "Absent Amino Acids": "ACDEGHIKMNOPRSTUVWY",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 4,
            "Polar Residues": 2,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02307",
                    "Similarity": 1.0,
                    "Sequence": "KMKYPEYGSLDLRRECRMGNGRCKNQCHENEIRIAYCIRPGTHCCLQQ"
                },
                {
                    "SPADE_ID": "SPADE_N_03164",
                    "Similarity": 1.0,
                    "Sequence": "KKKYPEYGSLDLRRECRIGNGQCKNQCHENEIRIAYCIRPGTHCCLQQ"
                },
                {
                    "SPADE_ID": "SPADE_N_13614",
                    "Similarity": 1.0,
                    "Sequence": "RECRIGNGQCKNQCHENEIRIAYCIRPGTHCCLQQ"
                }
            ]
        }
    }
}